TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.

Hedy L Kindler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.